Daily glucose self-monitoring in women with diet-treated gestational diabetes lowers the threat of delivering an oversized infant.
Daily glucose self-monitoring in women with diet-treated gestational diabetes lowers the threat of delivering an oversized infant, when compared to routine weekly monitoring, according to research published in the June issue of Obstetrics and Gynecology.
J. Seth Hawkins, MD, of the University of Texas Southwestern Medical Center in Dallas, and colleagues analyzed data from 990 women with diet-treated gestational diabetes who delivered between 1991 and 2001. Women who self-monitored their blood glucose four times daily were compared with those who underwent weekly routine office testing of their blood glucose.
The researchers found that the women in the daily self-monitoring group were less likely to have macrosomic infants-defined as 4,000 g or more-than the women in the weekly office-monitoring group (21.9% vs. 29.5%). They were also less likely to have large-for-gestational-age infants (23.1% vs. 34.4%). The authors further note that the daily self-monitoring group gained significantly less weight. However, they had higher average fasting glucose levels, and improvement of these values was similar between the groups.
Hawkins JS, Casey BM, Lo J, et al. Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol. 2009;113:1307-1312.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More